Trivalent; 5 ml mulitdose vial; vial contains ten 0.5 ml doses for flu season 2012-2013; for immunizing persons ages 36 months and older; contains thimerosal as a preservative; for intramuscular administration; requires refrigeration between 2 and 8 degrees c; do not freeze; 2012-2013 strains: a/california/7/2009 (h1n1)pdm09, the pandemic strain, a/victoria/361/2011 (h3n2), which replaces a/perth/16/2009, b/wisconsin/1/2010, which replaces b/brisbane/60/2008 and is of the yamagata lineage
Classification: Vaccines for human medicine
NSN 6130-01-469-1054
NSN 5935-01-500-1605
NSN 5999-01-374-0711
NSN 5920-00-501-7834
NSN 5835-00-289-9080
NSN 5975-00-113-7312
NSN 6130-01-444-1371
NSN 5998-00-437-6199
NSN 5935-00-572-7700
NSN 2925-01-273-4898
NSN 5965-00-905-6895
NSN 5985-00-786-5601